// App-Quantinova.ai

e18010 : Effect of the oral CXCR4 inhibitor X4-136 on tumor control and side effects in cervical cancer treated with radiotherapy and concurrent chemotherapy.

Researchers

Presenter

  • Naz Chaudary

Principal Investigators

  • Richard (Dick)

  • Lynne Kelley

  • Michael F. Milosevic

Medical Centers

  • Princess Margaret Cancer Center, Toronto, ON, Canada

  • Princess Margaret Cancer Centre, Radiation Medicine Program, University Health, University of Toronto, Toronto, ON, Canada

  • Merrimack Pharmaceuticals, Cambridge, MA

Locations

  • Canada

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • C-X-C motif chemokine receptor 4

Drug/Treatment

  • Cisplatin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved